GO
Loading...

Regeneron Pharmaceuticals CEO Talks Business

Tuesday, 8 Jan 2013 | 6:15 PM ET

Dr. Leonard Schleifer, president & CEO of Regeneron Pharmaceuticals, offers insight on EYLEA, which is used to treat macular degeneration -- the leading cause of blindness in elderly.